Atrás
34
También listada como
MAHLY
OTC
Rango del Día
$19.00
$19.00
Rango de 52 Semanas
$14.75
$19.00
Volumen
200
Promedio 50D / 200D
$18.50
/
$16.78
Cierre Anterior
$19.00
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.1 | 0.2 |
| P/B | 0.0 | 3.0 |
| ROE % | 6.6 | 3.6 |
| Net Margin % | 1.1 | 3.8 |
| Rev Growth 5Y % | 3.4 | 9.9 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.36
$1.34 – $1.37
|
4.21T | 1 |
| FY2029 |
$1.28
$1.27 – $1.30
|
4.02T | 1 |
| FY2028 |
$1.21
$1.20 – $1.23
|
3.98T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-09 | $0.32 | $0.48 | +48.4% |
| 2025-11-05 | $0.26 | $0.41 | +57.7% |
| 2025-08-05 | $0.32 | $0.32 | -0.6% |
| 2025-05-12 | $0.11 | $0.13 | +17.5% |
| 2025-02-10 | $0.22 | $0.44 | +100.6% |
| 2024-11-01 | $0.37 | $0.43 | +14.7% |
| 2024-08-01 | $0.35 | $0.27 | -23.9% |
| 2024-05-14 | $0.27 | $0.41 | +52.1% |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
0.31%
Growth (3Y)
7.31%
Growth (5Y)
1.81%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Mar 30, 2026 | $0.22 | 2.28% |
| Sep 30, 2025 | Dec 02, 2025 | $0.22 | 2.70% |
| Mar 31, 2025 | Jun 03, 2025 | $0.21 | 2.53% |
| Sep 30, 2024 | Dec 03, 2024 | $0.21 | 3.09% |
| Mar 28, 2024 | Jun 04, 2024 | $0.20 | 2.43% |
| Sep 28, 2023 | Dec 04, 2023 | $0.20 | 2.88% |
| Mar 30, 2023 | Jun 02, 2023 | $0.17 | 2.56% |
| Sep 29, 2022 | Dec 02, 2022 | $0.16 | 2.54% |
| Mar 30, 2022 | Jun 02, 2022 | $0.19 | 2.02% |
| Sep 29, 2021 | Dec 02, 2021 | $0.19 | 1.93% |
| Mar 30, 2021 | Jun 02, 2021 | $0.19 | 1.80% |
| Sep 29, 2020 | Dec 02, 2020 | $0.20 | 2.01% |
| Mar 30, 2020 | Jun 02, 2020 | $0.19 | 2.08% |
| Sep 27, 2019 | Dec 03, 2019 | $0.19 | 1.71% |
| Mar 27, 2019 | Jun 04, 2019 | $0.18 | 1.46% |
| Sep 26, 2018 | Dec 04, 2018 | $0.16 | 3.12% |
| Mar 28, 2018 | Jun 04, 2018 | $0.17 | 2.96% |
| Sep 27, 2017 | Dec 04, 2017 | $0.14 | 2.72% |
| Mar 29, 2017 | Jun 02, 2017 | $0.14 | 2.78% |
| Sep 28, 2016 | Dec 02, 2016 | $0.15 | 2.67% |
Puntos Clave
Revenue grew 3.40% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Generating 48.13B in free cash flow
P/E of 0.10 — trading at a low valuation
Cash machine — converts 119.49% of earnings into free cash flow
Capital efficient — spends only 0.34% of revenue on capex
Crecimiento
Revenue Growth (5Y)
3.40%
Revenue (1Y)3.16%
Earnings (1Y)-2.88%
FCF Growth (3Y)326.81%
Calidad
Return on Equity
6.60%
ROIC6.73%
Net Margin1.10%
Op. Margin1.51%
Seguridad
Debt / Equity
0.00
Current Ratio1.27
Interest Coverage7944.14
Valoración
P/E Ratio
0.10
Forward P/E15.24
P/B Ratio0.01
EV/EBITDA-4.63
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.16% | Revenue Growth (3Y) | 4.53% |
| Earnings Growth (1Y) | -2.88% | Earnings Growth (3Y) | 1.88% |
| Revenue Growth (5Y) | 3.40% | Earnings Growth (5Y) | 13.91% |
| Profitability | |||
| Revenue (TTM) | 3.67T | Net Income (TTM) | 40.28B |
| ROE | 6.60% | ROA | 2.21% |
| Gross Margin | 6.97% | Operating Margin | 1.51% |
| Net Margin | 1.10% | Free Cash Flow (TTM) | 48.13B |
| ROIC | 6.73% | FCF Growth (3Y) | 326.81% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 1.27 |
| Interest Coverage | 7944.14 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 0.31% |
| Dividend Growth (3Y) | 7.31% | Dividend Growth (5Y) | 1.81% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0.10 | Forward P/E | 15.24 |
| P/B Ratio | 0.01 | P/S Ratio | 0.00 |
| PEG Ratio | -9.71 | Forward PEG | N/A |
| EV/EBITDA | -4.63 | Fwd EV/EBITDA | -3.45 |
| Forward P/S | 0.00 | Fwd Earnings Yield | 6.56% |
| FCF Yield | 1237.45% | ||
| Market Cap | 3.89B | Enterprise Value | -257.52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.67T | 3.56T | 3.36T | 3.29T | 3.21T |
| Net Income | 40.28B | 41.47B | 38.81B | 29.42B | 23.93B |
| EPS (Diluted) | 193.20 | 195.83 | 179.12 | 131.41 | 106.80 |
| Gross Profit | 255.76B | 246.66B | 224.31B | 217.45B | 214.26B |
| Operating Income | 55.61B | 47.33B | 48.97B | 45.62B | 38.58B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.82T | 1.80T | 1.70T | 1.71T | 1.68T |
| Total Liabilities | 1.07T | 1.06T | 1.02T | 1.06T | 1.04T |
| Shareholders' Equity | 619.56B | 600.35B | 561.36B | 530.30B | 523.01B |
| Total Debt | 0.0 | 1.46B | 7.38B | 30.08B | 30.58B |
| Cash & Equivalents | 261.41B | 230.15B | 195.03B | 243.15B | 222.75B |
| Current Assets | 1.28T | 1.24T | 1.18T | 1.21T | 1.17T |
| Current Liabilities | 1.01T | 1.01T | 971.52B | 1.01T | 952.84B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#577 of 826
Actividad Reciente
Salió
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró
Defensive Investing (Benjamin Graham)
Mar 24, 2026